H

Houston Clinical Trials, LLC | Bellaire, TX

Research site

(Unclaimed)

Location

6330 West Loop South Suite 650, Bellaire, Texas, United States of America

Site insights

Top conditions

Top treatments

Rapastinel

SDX

Ecopipam

dexmethylphenidate

Serdexmethylphenidate

d-MPH

JZP150

Levomilnacipran

EYE103

CTx-1301

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

5 of 18 total trials

A Safety/Tolerability and PK Study With Azstarys® in Children With ADHD (KP415P02)

The is a multicenter, dose-optimized, open-label, safety/ tolerability and pharmacokinetic (PK) study with Azstarys® in children 4 and 5 years of age...

Active, not recruiting

Attention Deficit/Hyperactivity Disorder

Drug: Serdexmethylphenidate (SDX) and dexmethylphenidate (d-MPH)

A Study to Evaluate the Efficacy and Safety of 2 Doses of EYE103 Compared With Ranibizumab (0.5 mg) in Participants With DME (BRUNELLO)

EYE-RES-102 is a randomized, double masked pivotal study to evaluate the efficacy and safety of 2 dose levels of EYE103 in comparison with the active...

Enrolling

Diabetic Macular Edema (DME)

Drug: EYE103

Drug: Ranibizumab

A Study to Test Different Doses of BI 1569912 in People With Depression Who Take Anti-depressive Medicine

This study is open to adults between 18 and 65 with a type of depression (major depressive disorder) for whom previous treatments for depression did...

Enrolling

Depressive Disorder, Major

Drug: BI 1569912

Drug: Placebo

Long-term Safety Study of Rimegepant in Pediatric Subjects for the Acute Treatment of Migraine

The purpose of this study is to test the long-term safety of rimegepant in the acute treatment of moderate or severe migraine in children and adolesc...

Enrolling

Acute Treatment of Migraine

Drug: Rimegepant / BHV3000

Randomized Study in Children and Adolescents With Migraine: Acute Treatment

The purpose of this study is to test the safety and efficacy of BHV-3000 versus placebo in the acute treatment of moderate or severe migraine in chil...

Enrolling

Pediatric Migraine

Drug: Rimegepant/BHV3000

Drug: Matching placebo